Dorzolamide/timolol
From Wikipedia, the free encyclopedia
(Redirected from Cosopt)
| Combination of | |
|---|---|
| Dorzolamide | Carboanhydrase inhibitor |
| Timolol | Beta blocker |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | eye drops |
| Identifiers | |
| ATC code | S01ED51 |
| |
|
Dorzolamide/timolol eyedrops (trade name Cosopt) are used for lowering pressure in the eye to normal levels, and a treatment for glaucoma. The drug is a combination of two chemicals: dorzolamide hydrochloride and timolol maleate. It gained Food and Drug Administration (FDA) approval in April 1998, and is supplied by Merck.
[edit] External links
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
| This eye article is a stub. You can help Wikipedia by expanding it. |